European Medicines Agency Says First Ebola Vaccine Ready To Enter Market - UrduPoint
The European Medicines Agency (EMA) said on Friday it had recommended giving conditional marketing authorization for Ervebo, the first Ebola vaccine ever to be developed
MOSCOW (UrduPoint News / Sputnik - 18th October, 2019) The European Medicines Agency (EMA) said on Friday it had recommended giving conditional marketing authorization for Ervebo, the first Ebola vaccine ever to be developed.
"EMA's human medicines committee (CHMP) has recommended granting a conditional marketing authorization in the European Union for Ervebo ... the first vaccine for active immunization of individuals aged 18 years and older at risk of infection with the Ebola virus," the EMA said in a statement.
EMA Executive Director Guido Rasi praised the development of the vaccine, calling it an important step in the fight against the disease.
"The CHMP's recommendation is the result of many years of collaborative global efforts to find and develop new medicines and vaccines against Ebola. Public health authorities in countries affected by Ebola need safe and efficacious medicines to be able to respond effectively to outbreaks and save lives," Rasi said, as quoted by the EMA.
Ervebo started being developed after the 2014-2016 Ebola outbreak in West Africa, according to the statement. The medicine was tested on some 16,000 people in Europe, Africa and the United States, and proved to be safe as well as cable of creating an immune system that is effective against the type of Ebola that spread in western Africa several years ago.
The Ebola virus is transmitted to humans from wild animals and is estimated by the World Health Organization to have a 50 percent fatality rate. The outbreak in West Africa, the worst one ever recorded, killed more than 11,000 people among the some 28,000 cases reported. The Democratic Republic of the Congo is currently facing such an outbreak.
Your Thoughts and Comments
YAOUNDÉ, Cameroon - A leading U.S. Catholic aid agency will be working to "correct vaccine myths" as the World Health Organization prepares to begin using a second experimental Ebola vaccine in the Democratic Republic of
A GW Pharmaceuticals Cannabidiol oral solution, EPIDYOLEX®, is the first plant-derived cannabis-based medicine to be approved by the European Medicines Agency (EMA). EPIDYOLEX® cannabidiol oral solution contains highly purified, plant-derived cannabidiol (CBD), a cannabinoid
The aid agency has also called for an independent, international committee to manage Ebola vaccine stocks and their use International aid agency Médecins sans Frontiéres (MSF) has criticised the World Health Organization (WHO) for not providing
Germany, Switzerland and Austria are the first European countries to initiate recalls of ranitidine-based drugs after tests showed that certain products contained N-nitrosodimethylamine, a probable human carcinogen. With a Europe-wide review of ranitidine underway at the
More News in Health
They're popping up all over, and they're also quite healthy By Roberta Doster for The Columbian Published: October 18, 2019, 6:02am Pumpkins are crowding the sidewalks of our local grocery stores, glowing
LONDON (Reuters) - The world's first Ebola vaccine was approved by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a "triumph for public health" that would save
Between 2012 and 2016, there were an estimated 34,800 annual cases of human papilloma virus (HPV)-related cancer in the United States, 92% of which were attributed to strains of the virus covered by the 9-valent
When Howard Wolinsky, 72, received a prostate cancer diagnosis in 2010, the urologist at a community hospital wasted no time in presenting him with a range of treatment options: surgery, radiation and cryotherapy (freezing tissue
The government on Friday rolled out a free cervical cancer immunization program to young Kenyan girls countrywide. This makes Kenya the 16th nation in Africa to administer a vaccine against the cancer-causing Human Papillomavirus (HPV). The vaccination